The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 5
- 5 new
- Median first-year cost
- $485,000
- $2,711,575 in all
- Institutions
- 5
- 5 contact PIs
- Patents
- 1
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- BUCK INSTITUTE FOR RESEARCH ON AGING1
- CASE WESTERN RESERVE UNIVERSITY1
- UNIVERSITY OF PENNSYLVANIA1
- UNIVERSITY OF TEXAS HLTH SCIENCE CENTER1
- UNIVERSITY OF WASHINGTON1
Most frequent study sections
- ZAG1-ZIJ-P(A1)5
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2018 | Dissecting the Interplay between proteasome dysfunction, proteostasis and Alzheimer's disease1R56AG061051-01 | Pickering, Andrew Michael | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | First-year cost $733,916 | Study section ZAG1 |
| FY2018 | Pancreatic proteostasis connects sleep disruption to Alzheimers Disease1R56AG061057-01 | Baur, Joseph A.Naidoo, Nirmala Nirinjini | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $703,909 | Study section ZAG1 |
| FY2018 | Peripheral proteostasis and progression of AD related neurodegeneration: a Gut-Muscle-Brain triangle1R56AG057304-01A1 | Haghighi, Ali Pejmun | BUCK INSTITUTE FOR RESEARCH ON AGING, CA | First-year cost $485,000 | Study section ZAG1 |
| FY2018 | Contributions of osteoblastic and muscular APPswe to the pathogenesis of Alzheimers disease1R56AG060997-01 | Xiong, Wen-Cheng | CASE WESTERN RESERVE UNIVERSITY, OH | First-year cost $400,000 | Study section ZAG1 |
| FY2018 | Mechanisms of non-cell-autonomous regulation of brain protein aggregation in Drosophila1R56AG060963-01 | Pallanck, Leo J | UNIVERSITY OF WASHINGTON, WA | First-year cost $388,750 | Study section ZAG1 |
Patents from its funded projects
1 patent names 1 of the 5 funded projects.
- US 12,774,304 (opens the patent at USPTO, a PDF, in a new tab)PEPTIDE-BASED COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASEGranted October 27, 2026 to Board of Regents, The University of Texas SystemR56AG061051 · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.